MARKET

SHIEF

SHIEF

Shield Therapeut
OTCMQB
0.146
NaN%
Opening 09:30 02/09 EST
OPEN
--
PREV CLOSE
0.146
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.146
52 WEEK LOW
0.039
MARKET CAP
155.93M
P/E (TTM)
-6.0581
1D
5D
1M
3M
1Y
5Y
1D
Shield Therapeutics Wins Extra U.S. FDA Exclusivity for ACCRUFeR Pediatric Use
TipRanks · 9h ago
IBM erhält Auftrag zur Unterstützung des SHIELD-Programms der Missile Defense Agency
Reuters · 4d ago
Shield Therapeutics Updates Market on Total Voting Rights and Share Capital
TipRanks · 01/30 08:21
Shield Therapeutics Secures $7.9m China Milestone as ACCRUFeR® Nears NMPA Filing
TipRanks · 01/30 07:32
Shield Therapeutics Hits Q4 Cash Flow Positivity as ACCRUFeR Sales Jump 56% in 2025
TipRanks · 01/21 07:12
EUROPE RESEARCH ROUNDUP-Aedifica, Montana Aerospace, Sodexo
Reuters · 01/12 07:24
Shield Therapeutics Confirms Total Voting Rights and Share Capital Structure
TipRanks · 01/02 07:18
Shield Therapeutics Wins FDA Nod to Extend ACCRUFeR Use to Adolescents
TipRanks · 12/22/2025 07:13
More
About SHIEF
Shield Therapeutics plc is a United Kingdom-based commercial-stage pharmaceutical company. The Company delivers differentiated specialty pharmaceuticals that address a significant unmet need for patients suffering from iron deficiency, with or without anemia. The Company’s lead product, Accrufer/Feraccru, is broadly indicated for use in adults across multiple therapeutic categories. Ferric maltol is approved in the United States, European Union, the United Kingdom, Canada, Australia and Switzerland for the treatment of iron deficiency with or without anemia in adults. It also has an exclusive licence agreement with Beijing Aosaikang Pharmaceutical Co., Ltd., for the development and commercialization of ACCRUFeR/FeRACCRU in China, Hong Kong, Macau and Taiwan, with Korea Pharma Co., Ltd. for the Republic of Korea. The Company's subsidiaries include Phosphate Therapeutics Limited, Shield TX (Switzerland) AG, Shield Therapeutics Inc, and Shield TX (UK) Limited.

Webull offers Shield Therapeutics PLC stock information, including OTCMQB: SHIEF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SHIEF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SHIEF stock methods without spending real money on the virtual paper trading platform.